keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Onvitrelin ucalontide ([Phor18-LHRH (338613)]) is a luteinizing hormone-releasing hormone (LHRH) analogue possessing antineoplastic properties, characterized by the peptide sequence KFAKFAKKFAKFAKKFAKQHWSYGLRPG. It demonstrates effectiveness in inhibiting breast, ovarian, and prostate cancer xenografts in mouse models [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Onvitrelin ucalontide ([Phor18-LHRH (338613)]) is a luteinizing hormone-releasing hormone (LHRH) analogue possessing antineoplastic properties, characterized by the peptide sequence KFAKFAKKFAKFAKKFAKQHWSYGLRPG. It demonstrates effectiveness in inhibiting breast, ovarian, and prostate cancer xenografts in mouse models [1] [2]. |
Molecular Weight | 3316.94 |
Formula | C163H243N43O32 |
CAS No. | 1174415-90-7 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Onvitrelin ucalontide 1174415-90-7 inhibitor inhibit